BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 22723229)

  • 1. Facial filler and neurotoxin complications.
    Nettar K; Maas C
    Facial Plast Surg; 2012 Jun; 28(3):288-93. PubMed ID: 22723229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lasers, fillers, and neurotoxins: avoiding complications in the cosmetic facial practice.
    Hassouneh B; Newman JP
    Facial Plast Surg Clin North Am; 2013 Nov; 21(4):585-98. PubMed ID: 24200377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of dermal filler complications.
    Winslow CP
    Facial Plast Surg; 2009 May; 25(2):124-8. PubMed ID: 19415581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
    Kenner JR
    J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable neurotoxins and fillers: there is no free lunch.
    Emer J; Waldorf H
    Clin Dermatol; 2011; 29(6):678-90. PubMed ID: 22014990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive periorbital rejuvenation.
    Hoenig J; Hoenig D
    Facial Plast Surg; 2013 Aug; 29(4):295-309. PubMed ID: 23884851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulators: available agents, physiology, and anatomy.
    Nettar K; Maas C
    Facial Plast Surg; 2011 Dec; 27(6):517-22. PubMed ID: 22205524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable success: from fillers to Botox.
    Kelly PE
    Facial Plast Surg; 2007 Feb; 23(1):7-18; discussion 19-20. PubMed ID: 17330767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications from toxins and fillers in the dermatology clinic: recognition, prevention, and treatment.
    Dayan SH
    Facial Plast Surg Clin North Am; 2013 Nov; 21(4):663-73. PubMed ID: 24200384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal fillers for facial soft tissue augmentation.
    Dastoor SF; Misch CE; Wang HL
    J Oral Implantol; 2007; 33(4):191-204. PubMed ID: 17912960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable treatments for the aging face.
    Wise JB; Greco T
    Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of hyaluronic acid fillers.
    Weinberg MJ; Solish N
    Facial Plast Surg; 2009 Dec; 25(5):324-8. PubMed ID: 20024874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers: Safety and Current Use.
    Fabi SG; Goldman MP; Mills DC; Werschler WP; Green JB; Kaufman J; Weiss RA; Hornfeldt CS
    Dermatol Surg; 2016 May; 42 Suppl 2():S168-76. PubMed ID: 27128245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvéderm: a hyaluronic acid dermal filler.
    Monheit GD; Prather CL
    J Drugs Dermatol; 2007 Nov; 6(11):1091-5. PubMed ID: 18038495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials.
    Vargas-Machuca I; González-Guerra E; Angulo J; del Carmen Fariña M; Martín L; Requena L
    Am J Dermatopathol; 2006 Apr; 28(2):173-7. PubMed ID: 16625084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid fillers.
    Monheit GD; Coleman KM
    Dermatol Ther; 2006; 19(3):141-50. PubMed ID: 16784513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of injectable soft tissue filler complications.
    Sclafani AP; Fagien S
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1672-80. PubMed ID: 19807763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable Filler Techniques for Facial Rejuvenation, Volumization, and Augmentation.
    Bass LS
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):479-88. PubMed ID: 26505544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.